Annual Gross Profit
$73.07 M
+$24.56 M+50.63%
31 December 2023
Summary:
Esperion Therapeutics annual gross profit is currently $73.07 million, with the most recent change of +$24.56 million (+50.63%) on 31 December 2023. During the last 3 years, it has fallen by -$152.09 million (-67.55%). ESPR annual gross profit is now -67.55% below its all-time high of $225.16 million, reached on 31 December 2020.ESPR Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$34.35 M
-$23.88 M-41.01%
30 September 2024
Summary:
Esperion Therapeutics quarterly gross profit is currently $34.35 million, with the most recent change of -$23.88 million (-41.01%) on 30 September 2024. Over the past year, it has increased by +$13.75 million (+66.79%). ESPR quarterly gross profit is now -83.79% below its all-time high of $211.84 million, reached on 30 June 2020.ESPR Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$241.03 M
+$13.75 M+6.05%
30 September 2024
Summary:
Esperion Therapeutics TTM gross profit is currently $241.03 million, with the most recent change of +$13.75 million (+6.05%) on 30 September 2024. Over the past year, it has increased by +$174.10 million (+260.14%). ESPR TTM gross profit is now at all-time high.ESPR TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +50.6% | +66.8% | +260.1% |
| 3 y3 years | -67.5% | +288.1% | +289.7% |
| 5 y5 years | +100.0% | +3401.1% | +63.5% |
ESPR Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -67.5% | +50.6% | -73.1% | +288.1% | at high | +494.4% |
| 5 y | 5 years | -67.5% | -83.8% | +3401.1% | at high | +4970.0% | |
| alltime | all time | -67.5% | +9419.8% | -83.8% | +3401.1% | at high | +4970.0% |
Esperion Therapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $34.35 M(-41.0%) | $241.03 M(+6.1%) |
| June 2024 | - | $58.23 M(-54.4%) | $227.28 M(+20.9%) |
| Mar 2024 | - | $127.66 M(+513.8%) | $188.05 M(+157.4%) |
| Dec 2023 | $73.07 M(+50.6%) | $20.80 M(+1.0%) | $73.07 M(+9.2%) |
| Sept 2023 | - | $20.59 M(+8.4%) | $66.93 M(+13.8%) |
| June 2023 | - | $19.00 M(+49.9%) | $58.81 M(+18.9%) |
| Mar 2023 | - | $12.68 M(-13.5%) | $49.47 M(+2.0%) |
| Dec 2022 | $48.51 M(-24.5%) | $14.66 M(+17.5%) | $48.51 M(+9.8%) |
| Sept 2022 | - | $12.47 M(+29.1%) | $44.18 M(+8.9%) |
| June 2022 | - | $9.66 M(-17.5%) | $40.55 M(-41.9%) |
| Mar 2022 | - | $11.71 M(+13.4%) | $69.75 M(+8.6%) |
| Dec 2021 | $64.23 M | $10.33 M(+16.7%) | $64.23 M(+3.8%) |
| Sept 2021 | - | $8.85 M(-77.2%) | $61.85 M(+9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $38.86 M(+527.4%) | $56.56 M(-75.4%) |
| Mar 2021 | - | $6.19 M(-22.1%) | $229.54 M(+1.9%) |
| Dec 2020 | $225.16 M(+51.8%) | $7.95 M(+123.4%) | $225.16 M(+3.2%) |
| Sept 2020 | - | $3.56 M(-98.3%) | $218.19 M(+1.2%) |
| June 2020 | - | $211.84 M(>+9900.0%) | $215.61 M(+4435.3%) |
| Mar 2020 | - | $1.81 M(+84.2%) | $4.75 M(-96.8%) |
| Dec 2019 | $148.36 M(>+9900.0%) | $982.00 K(+0.1%) | $148.36 M(+0.7%) |
| Sept 2019 | - | $981.00 K(-0.1%) | $147.38 M(+0.7%) |
| June 2019 | - | $982.00 K(-99.3%) | $146.40 M(+0.7%) |
| Mar 2019 | - | $145.42 M | $145.42 M |
| Dec 2018 | $0.00(-100.0%) | - | - |
| Dec 2000 | -$784.00 K(+15.0%) | - | - |
| Dec 1999 | -$682.00 K | - | - |
FAQ
- What is Esperion Therapeutics annual gross profit?
- What is the all time high annual gross profit for Esperion Therapeutics?
- What is Esperion Therapeutics annual gross profit year-on-year change?
- What is Esperion Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly gross profit year-on-year change?
- What is Esperion Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for Esperion Therapeutics?
- What is Esperion Therapeutics TTM gross profit year-on-year change?
What is Esperion Therapeutics annual gross profit?
The current annual gross profit of ESPR is $73.07 M
What is the all time high annual gross profit for Esperion Therapeutics?
Esperion Therapeutics all-time high annual gross profit is $225.16 M
What is Esperion Therapeutics annual gross profit year-on-year change?
Over the past year, ESPR annual gross profit has changed by +$24.56 M (+50.63%)
What is Esperion Therapeutics quarterly gross profit?
The current quarterly gross profit of ESPR is $34.35 M
What is the all time high quarterly gross profit for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly gross profit is $211.84 M
What is Esperion Therapeutics quarterly gross profit year-on-year change?
Over the past year, ESPR quarterly gross profit has changed by +$13.75 M (+66.79%)
What is Esperion Therapeutics TTM gross profit?
The current TTM gross profit of ESPR is $241.03 M
What is the all time high TTM gross profit for Esperion Therapeutics?
Esperion Therapeutics all-time high TTM gross profit is $241.03 M
What is Esperion Therapeutics TTM gross profit year-on-year change?
Over the past year, ESPR TTM gross profit has changed by +$174.10 M (+260.14%)